BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 19441605)

  • 41. Effects of topical corticosteroid and combined mediator blockade on domiciliary and laboratory measurements of nasal function in seasonal allergic rhinitis.
    Wilson AM; Sims EJ; Orr LC; Coutie WJ; White PS; Gardiner Q; Lipworth BJ
    Ann Allergy Asthma Immunol; 2001 Oct; 87(4):344-9. PubMed ID: 11686428
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The effect of montelukast on rhinitis symptoms in patients with asthma and seasonal allergic rhinitis.
    Philip G; Nayak AS; Berger WE; Leynadier F; Vrijens F; Dass SB; Reiss TF
    Curr Med Res Opin; 2004 Oct; 20(10):1549-58. PubMed ID: 15462688
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A review of the efficacy of desloratadine, fexofenadine, and levocetirizine in the treatment of nasal congestion in patients with allergic rhinitis.
    Bachert C
    Clin Ther; 2009 May; 31(5):921-44. PubMed ID: 19539095
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Comparative onset of action and symptom relief with cetirizine, loratadine, or placebo in an environmental exposure unit in subjects with seasonal allergic rhinitis: confirmation of a test system.
    Day JH; Briscoe M; Rafeiro E; Chapman D; Kramer B
    Ann Allergy Asthma Immunol; 2001 Dec; 87(6):474-81. PubMed ID: 11770694
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A comparison of the effect of diphenhydramine and desloratadine on vigilance and cognitive function during treatment of ragweed-induced allergic rhinitis.
    Wilken JA; Kane RL; Ellis AK; Rafeiro E; Briscoe MP; Sullivan CL; Day JH
    Ann Allergy Asthma Immunol; 2003 Oct; 91(4):375-85. PubMed ID: 14582817
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Oral Phenylephrine HCl for Nasal Congestion in Seasonal Allergic Rhinitis: A Randomized, Open-label, Placebo-controlled Study.
    Meltzer EO; Ratner PH; McGraw T
    J Allergy Clin Immunol Pract; 2015; 3(5):702-8. PubMed ID: 26143019
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A Randomized, Multicenter, Double-blind, Phase III Study to Evaluate the Efficacy on Allergic Rhinitis and Safety of a Combination Therapy of Montelukast and Levocetirizine in Patients With Asthma and Allergic Rhinitis.
    Kim MK; Lee SY; Park HS; Yoon HJ; Kim SH; Cho YJ; Yoo KH; Lee SK; Kim HK; Park JW; Park HW; Chung JH; Choi BW; Lee BJ; Chang YS; Jo EJ; Lee SY; Cho YS; Jee YK; Lee JM; Jung J; Park CS
    Clin Ther; 2018 Jul; 40(7):1096-1107.e1. PubMed ID: 29945738
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Clinical studies of the DP1 antagonist laropiprant in asthma and allergic rhinitis.
    Philip G; van Adelsberg J; Loeys T; Liu N; Wong P; Lai E; Dass SB; Reiss TF
    J Allergy Clin Immunol; 2009 Nov; 124(5):942-8.e1-9. PubMed ID: 19748656
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A comparison of the efficacy of fluticasone propionate aqueous nasal spray and loratadine, alone and in combination, for the treatment of seasonal allergic rhinitis.
    Ratner PH; van Bavel JH; Martin BG; Hampel FC; Howland WC; Rogenes PR; Westlund RE; Bowers BW; Cook CK
    J Fam Pract; 1998 Aug; 47(2):118-25. PubMed ID: 9722799
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Combination therapy with montelukast and loratadine alleviates pharyngolaryngeal symptoms related to seasonal allergic rhinitis.
    Imoto Y; Takabayashi T; Sakashita M; Tokunaga T; Morikawa T; Ninomiya T; Okamoto M; Narita N; Fujieda S
    J Allergy Clin Immunol Pract; 2019 Mar; 7(3):1068-1070.e3. PubMed ID: 30103031
    [No Abstract]   [Full Text] [Related]  

  • 51. Efficacy of the novel nasal steroid S0597 tested in an environmental exposure unit.
    Ellis AK; Steacy LM; Joshi A; Bhowmik S; Raut A
    Ann Allergy Asthma Immunol; 2016 Sep; 117(3):310-7. PubMed ID: 27613466
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A randomized, double-blind, placebo-controlled study comparing the efficacy and safety of ebastine (20 mg and 10 mg) to loratadine 10 mg once daily in the treatment of seasonal allergic rhinitis.
    Hampel F; Howland W; Van Bavel J; Ratner P
    J Investig Allergol Clin Immunol; 2004; 14(1):56-63. PubMed ID: 15160443
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Onset of action and efficacy of terfenadine, astemizole, cetirizine, and loratadine for the relief of symptoms of allergic rhinitis.
    Day JH; Briscoe MP; Clark RH; Ellis AK; Gervais P
    Ann Allergy Asthma Immunol; 1997 Aug; 79(2):163-72. PubMed ID: 9291422
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Loratadine/pseudoephedrine for nasal symptoms in seasonal allergic rhinitis: a double-blind, placebo-controlled study.
    McFadden EA; Gungor A; Ng B; Mamikoglu B; Moinuddin R; Corey J
    Ear Nose Throat J; 2000 Apr; 79(4):254, 257-8, 260 passim. PubMed ID: 10786387
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Efficacy of azelastine nasal spray in patients with an unsatisfactory response to loratadine.
    Berger WE; White MV;
    Ann Allergy Asthma Immunol; 2003 Aug; 91(2):205-11. PubMed ID: 12952117
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Comparative efficacy and safety of a once-daily loratadine-pseudoephedrine combination versus its components alone and placebo in the management of seasonal allergic rhinitis.
    Bronsky E; Boggs P; Findlay S; Gawchik S; Georgitis J; Mansmann H; Sholler L; Wolfe J; Meltzer E; Morris R
    J Allergy Clin Immunol; 1995 Aug; 96(2):139-47. PubMed ID: 7636050
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Montelukast plus cetirizine in the prophylactic treatment of seasonal allergic rhinitis: influence on clinical symptoms and nasal allergic inflammation.
    Kurowski M; Kuna P; Górski P
    Allergy; 2004 Mar; 59(3):280-8. PubMed ID: 14982509
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Efficacy of nasal corticosteroids alone or combined with antihistamines or montelukast in treatment of allergic rhinitis.
    Pinar E; Eryigit O; Oncel S; Calli C; Yilmaz O; Yuksel H
    Auris Nasus Larynx; 2008 Mar; 35(1):61-6. PubMed ID: 17826020
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Evaluation of treatment response in patients with seasonal allergic rhinitis using domiciliary nasal peak inspiratory flow.
    Wilson A; Dempsey OJ; Sims EJ; Coutie WJ; Paterson MC; Lipworth BJ
    Clin Exp Allergy; 2000 Jun; 30(6):833-8. PubMed ID: 10848901
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Safety and efficacy of desloratadine 5 mg in asthma patients with seasonal allergic rhinitis and nasal congestion.
    Berger WE; Schenkel EJ; Mansfield LE;
    Ann Allergy Asthma Immunol; 2002 Nov; 89(5):485-91. PubMed ID: 12452207
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.